AU2006299521A1 - Transdermal drug delivery systems, devices, and methods employing opioid agonist and/or opioid antagonist - Google Patents

Transdermal drug delivery systems, devices, and methods employing opioid agonist and/or opioid antagonist Download PDF

Info

Publication number
AU2006299521A1
AU2006299521A1 AU2006299521A AU2006299521A AU2006299521A1 AU 2006299521 A1 AU2006299521 A1 AU 2006299521A1 AU 2006299521 A AU2006299521 A AU 2006299521A AU 2006299521 A AU2006299521 A AU 2006299521A AU 2006299521 A1 AU2006299521 A1 AU 2006299521A1
Authority
AU
Australia
Prior art keywords
active agent
opioid antagonist
opioid
active
electrode assembly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006299521A
Other languages
English (en)
Inventor
Darrick Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TTI Ellebeau Inc
Original Assignee
TTI Ellebeau Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TTI Ellebeau Inc filed Critical TTI Ellebeau Inc
Publication of AU2006299521A1 publication Critical patent/AU2006299521A1/en
Assigned to TTI ELLEBEAU, INC. reassignment TTI ELLEBEAU, INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: TTI ELLEBEAU, INC.
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0444—Membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details
    • A61N1/306—Arrangements where at least part of the apparatus is introduced into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrotherapy Devices (AREA)
AU2006299521A 2005-09-30 2006-09-29 Transdermal drug delivery systems, devices, and methods employing opioid agonist and/or opioid antagonist Abandoned AU2006299521A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72213605P 2005-09-30 2005-09-30
US60/722,136 2005-09-30
PCT/US2006/038549 WO2007041544A1 (en) 2005-09-30 2006-09-29 Transdermal drug delivery systems, devices, and methods employing opioid agonist and/or opioid antagonist

Publications (1)

Publication Number Publication Date
AU2006299521A1 true AU2006299521A1 (en) 2007-04-12

Family

ID=37696075

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006299521A Abandoned AU2006299521A1 (en) 2005-09-30 2006-09-29 Transdermal drug delivery systems, devices, and methods employing opioid agonist and/or opioid antagonist

Country Status (10)

Country Link
EP (1) EP1931421A1 (enExample)
JP (1) JP2009509692A (enExample)
KR (1) KR20080058433A (enExample)
CN (2) CN101321554A (enExample)
AU (1) AU2006299521A1 (enExample)
BR (1) BRPI0616788A2 (enExample)
CA (1) CA2622684A1 (enExample)
IL (1) IL190245A0 (enExample)
RU (1) RU2008117168A (enExample)
WO (1) WO2007041544A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100239523A1 (en) * 2007-10-30 2010-09-23 The Regents Of The University Of Colorado Tlr modulators and methods for using the same
AU2009225434B2 (en) 2008-03-21 2014-05-22 The University Of Chicago Treatment with opioid antagonists and mTOR inhibitors
EP2303016A4 (en) 2008-05-01 2011-11-30 Univ California METHOD AND USE FOR THE USE OF SELECTIVE DELTA OPIOID RECEPTOR 1 AGONISTS, DELTA OPIOID RECEPTOR 2 AGONISTS AND / OR MU OPIOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ACTIVE SUBSTANCES
WO2010110397A1 (ja) * 2009-03-25 2010-09-30 国立大学法人 香川大学 マイクロニードルおよびその製造方法と金型
CA2841785A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
CN106730311B (zh) * 2016-12-27 2019-10-29 潍坊大地医疗器械有限公司 经络综合治疗仪电极触头装置
JP2020503950A (ja) 2017-01-06 2020-02-06 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 経皮薬剤送達の装置及び方法
GB201704909D0 (en) 2017-03-28 2017-05-10 Ldn Pharma Ltd Cancer therapy
WO2019090125A2 (en) * 2017-11-02 2019-05-09 Chrono Therapeutics Inc. Smart abuse-deterrent transdermal drug delivery system
JP7420797B2 (ja) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド 薬剤送達の方法及びシステム
CA3119992A1 (en) 2018-11-16 2020-05-22 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
ES3011582T3 (en) 2019-02-21 2025-04-07 Pharmaceutical Productions Inc Naloxone formulations for sublingual and/or buccal administration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
US4879297A (en) * 1987-06-01 1989-11-07 Warner-Lambert Company Fatty acids and their small chain esters as penetration enhancers in aqueous systems
US5312326A (en) * 1992-06-02 1994-05-17 Alza Corporation Iontophoretic drug delivery apparatus
EA009921B1 (ru) * 2003-07-25 2008-04-28 Еуро-Селтик С.А. Способ лечения синдрома отвыкания от зависимости у беременных женщин
TW200640526A (en) * 2005-02-24 2006-12-01 Alza Corp Transdermal electrotransport drug delivery systems with reduced abuse potential

Also Published As

Publication number Publication date
BRPI0616788A2 (pt) 2011-07-05
WO2007041544A1 (en) 2007-04-12
CN101321554A (zh) 2008-12-10
CA2622684A1 (en) 2007-04-12
KR20080058433A (ko) 2008-06-25
JP2009509692A (ja) 2009-03-12
CN101316623A (zh) 2008-12-03
RU2008117168A (ru) 2009-11-10
EP1931421A1 (en) 2008-06-18
IL190245A0 (en) 2008-11-03

Similar Documents

Publication Publication Date Title
US7848801B2 (en) Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
US20070093789A1 (en) Iontophoresis apparatus and method for delivery of angiogenic factors to enhance healing of injured tissue
US20080058701A1 (en) Delivery device having self-assembling dendritic polymers and method of use thereof
US20070093788A1 (en) Iontophoresis method and apparatus for systemic delivery of active agents
US20070093787A1 (en) Iontophoresis device to deliver multiple active agents to biological interfaces
US20070110810A1 (en) Transdermal drug delivery systems, devices, and methods employing hydrogels
US20070078376A1 (en) Functionalized microneedles transdermal drug delivery systems, devices, and methods
US20080033398A1 (en) Device and method for enhancing immune response by electrical stimulation
US7574256B2 (en) Iontophoretic device and method of delivery of active agents to biological interface
EP2059298A2 (en) Transdermal drug delivery systems, devices, and methods using inductive power supplies
AU2006299521A1 (en) Transdermal drug delivery systems, devices, and methods employing opioid agonist and/or opioid antagonist
US20070081944A1 (en) Iontophoresis apparatus and method for the diagnosis of tuberculosis
MX2008004223A (en) Transdermal drug delivery systems, devices, andmethods employing opioid agonist and/or opioid antagonist
HK1125876A (en) Transdermal drug delivery systems, devices, and methods employing opioid agonist and/or opioid antagonist
MX2008004224A (es) Metodo y aparato de iontoforesis para el suministro sistemico de agentes activos
HK1125875A (en) Iontophoresis method and apparatus for systemic delivery of active agents

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application